At the 2026 ARDD meeting in Boston, executives from Pfizer, GSK, AstraZeneca, Novartis and Eli Lilly discussed longevity drugs as the FDA promised new clinical trial guidance next year.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
